Modular Medical Operating Income Over Time
| MODD Stock | USD 0.44 0.02 4.35% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Modular Medical Performance and Modular Medical Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Modular diversify its offerings? Factors like these will boost the valuation of Modular Medical. Expected growth trajectory for Modular significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Modular Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Modular Medical requires distinguishing between market price and book value, where the latter reflects Modular's accounting equity. The concept of intrinsic value - what Modular Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Modular Medical's price substantially above or below its fundamental value.
Understanding that Modular Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Modular Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Modular Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare Modular Medical and related stocks such as Vicarious Surgical, Nexalin Technology, and iBio Common Stock Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RBOT | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (13 M) | (38.2 M) | (80.1 M) | (80.7 M) | (66.6 M) | (59.9 M) | (62.9 M) |
| NXL | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (3.3 M) | (6 M) | (1.8 M) | (5.7 M) | (7.8 M) | (7 M) | (6.6 M) |
| IBIO | (1.7 M) | (9.3 M) | (6.7 M) | (3.8 M) | (6.7 M) | (9.9 M) | (14.3 M) | (14.2 M) | (15.8 M) | (14 M) | (31.1 M) | (29.7 M) | (29.3 M) | (16.6 M) | (18.6 M) | (16.7 M) | (17.6 M) |
| HYPD | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (13 M) | (26.9 M) | (25.4 M) | (48.7 M) | (43.9 M) | (41.7 M) |
| ITRM | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (13.4 M) | (29.5 M) | (76.6 M) | (102 M) | (32.1 M) | (24.5 M) | (30.4 M) | (47.5 M) | (18.7 M) | (21.5 M) | (22.6 M) |
| MYO | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (3.5 M) | (3.3 M) | (6.5 M) | (10.5 M) | (10.8 M) | (10.5 M) | (10.3 M) | (10.7 M) | (8.2 M) | (6.2 M) | (5.6 M) | (5.9 M) |
| ANTX | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (7.3 M) | (21.6 M) | (42.3 M) | (69.6 M) | (54.6 M) | (49.1 M) | (51.6 M) |
| INTS | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (6.2 M) | (8 M) | (7.5 M) | (8.3 M) | (16.6 M) | (14.9 M) | (14.2 M) |
| BOLD | (60 M) | (60 M) | (60 M) | (60 M) | (60 M) | (60 M) | (60 M) | (93.2 M) | (134.4 M) | (25.3 M) | (25.3 M) | (25.3 M) | (46.5 M) | (54.8 M) | (73.3 M) | (84.3 M) | (88.5 M) |
| IINN | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (1.3 M) | (6.3 M) | (12.2 M) | 14.9 M | (12.1 M) | 11.3 K | 10.1 K | 10.6 K |
Modular Medical and related stocks such as Vicarious Surgical, Nexalin Technology, and iBio Common Stock Operating Income description
Operating Income is the amount of profit realized from Modular Medical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Modular Medical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Modular Medical | MODD |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 10740 Thornmint Road, |
| Exchange | NASDAQ Exchange |
USD 0.44
Check out Modular Medical Performance and Modular Medical Correlation. For information on how to trade Modular Stock refer to our How to Trade Modular Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Modular Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.